logo
Raymond shares gain over 4% as Govt exempts cotton imports from duty till Sept 30

Raymond shares gain over 4% as Govt exempts cotton imports from duty till Sept 30

Business Upturn2 hours ago
By Aditya Bhagchandani Published on August 19, 2025, 09:28 IST
Shares of Raymond Ltd surged over 4% to ₹637.75 in early trade on Monday after the government temporarily removed the 11% customs duty on raw cotton imports till September 30. The move comes as a major relief to the textile and garment sector, which has been grappling with rising input costs and stiff competition in global markets.
The Finance Ministry, through the Central Board of Indirect Taxes and Customs (CBIC), notified the exemption, which covers both the basic customs duty and the Agriculture Infrastructure and Development Cess (AIDC) on raw cotton. The decision will remain in effect for 42 days, from August 19 to September 30.
The step is expected to provide immediate cost relief across the textile value chain — from yarn and fabric producers to garment makers. Industry body CITI (Confederation of Indian Textile Industry) welcomed the move, noting it will help domestic cotton prices align with international benchmarks and improve export competitiveness.
For Raymond, a diversified player in textiles, garments, and lifestyle products, the exemption is likely to support margins in the short term. Exporters like Raymond, who are dealing with the adverse impact of 50% tariffs on Indian textiles in the US, see this as a critical breather as they face rising pressure from global rivals such as Bangladesh, Vietnam, and China.
Analysts say while the relief is temporary, it signals government intent to support the sector at a crucial time. Exporters continue to hope for an extension of the duty removal and stronger trade negotiations with the US to secure long-term competitiveness.
Raymond's gains were in line with a broader rally in textile stocks, with peers such as Welspun Living, Vardhman Textiles, Arvind, and Trident also trading higher on the back of the duty exemption announcement.
Ahmedabad Plane Crash
Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

India's Modi to meet China's top diplomat as Asian powers rebuild ties

time29 minutes ago

India's Modi to meet China's top diplomat as Asian powers rebuild ties

NEW DELHI -- NEW DELHI (AP) — Indian Prime Minister Narendra Modi will meet with China's top diplomat on Tuesday in a sign of easing tensions between the nuclear-armed neighbors after a yearslong standoff between the Asian powers. Chinese Foreign Minister Wang Yi, who arrived in India on Monday, is scheduled to hold talks with Modi and other leaders, including National Security Adviser Ajit Doval, about the disputed border in the Himalayan mountains. Reducing the number of troops on the border, and resuming some trade there, is expected to be on the agenda. The rebuilding of ties coincides with friction between New Delhi and Washington after U.S. President Donald Trump imposed steep tariffs on India, a longtime ally seen as a counterbalance against China's influence in Asia. India is part of the Quad security alliance with the U.S. along with Australia and Japan. India and China's decades-old border dispute worsened in 2020 after a deadly clash between their troops in the Ladakh region. The chill in relations affected trade, diplomacy and air travel as both sides deployed tens of thousands of security forces in border areas. Some progress has been made since then. Last year, India and China agreed to a pact on border patrols and withdrew additional forces along some border areas. Both countries continue to fortify their border by building roads and rail networks. In recent months, the countries have increased official visits and discussed easing some trade restrictions, movement of citizens and visas for businesspeople. In June, Beijing allowed pilgrims from India to visit holy sites in Tibet. Both sides are working to restore direct flights. Last week, the spokesman for India's foreign ministry, Randhir Jaiswal, said India and China were in discussions to restart trade through three points along their 3,488-kilometer (2,167-mile) border. Manoj Joshi, a fellow at the Observer Research Foundation, a New Delhi-based think tank, said relations are still at an uneasy level of normalization. 'Settling the boundary issue between the two countries requires political compromise at the highest political level,' said Joshi, who also served as a member of the advisory board for India's National Security Council. He asserted that the countries are "still talking past each other when it comes to the border dispute and issues surrounding it." On Monday, China's Foreign Ministry spokesperson Mao Ning said Beijing is willing to take Wang's India visit as an opportunity to work with the Indian side to 'properly handle differences and promote the sustained, sound and stable development of China-India relations.' Mao said Wang's meeting with Modi's national security adviser will 'continue in-depth communication to jointly safeguard peace and tranquility in the border areas.' The thaw between Beijing and New Delhi began last October when Modi and Chinese President Xi Jinping met at a summit of emerging economies in Russia. It was the first time the leaders had spoken in person since 2019. Modi is set to met Xi when he travels to China late this month — his first visit in seven years — to attend the summit of the Shanghai Cooperation Organization, a regional grouping formed by China, Russia and others to counter U.S. influence in Asia. Earlier this year, Xi called for India and China's relations to take the form of a 'dragon-elephant tango' — a dance between the emblematic animals of the countries. Last month, India's external affairs minister visited Beijing in his first trip to China since 2020. The renewed engagement comes as New Delhi's ties with Trump are fraying. Washington has imposed a 50% tariff on Indian goods, which includes a penalty of 25% for purchasing Russian crude oil. The tariffs take effect Aug. 27. India has shown no sign of backing down, instead signing more agreements with Russia to deepen economic cooperation. Trump's renewed engagement with India's arch rival, Pakistan, has also encouraged New Delhi's overtures to China, said Lt. Gen. D.S. Hooda, who led Indian military's Northern Command from 2014 to 2016. In June, Trump hosted Pakistan's army chief for a White House lunch and later announced an energy deal with Islamabad to jointly develop the country's oil reserves. Both followed Trump's claims of brokering a ceasefire between India and Pakistan after the two sides traded military strikes in May. 'China is heavily invested in Pakistan and, practically speaking, you can't have any expectation that Beijing will hold back support to Islamabad," Hooda said. 'But you can't have two hostile neighbors on your borders and simultaneously deal with them also.'

Alembic Pharma gains as USFDA approves Macitentan tablets for pulmonary arterial hypertension
Alembic Pharma gains as USFDA approves Macitentan tablets for pulmonary arterial hypertension

Business Upturn

time42 minutes ago

  • Business Upturn

Alembic Pharma gains as USFDA approves Macitentan tablets for pulmonary arterial hypertension

By Aditya Bhagchandani Published on August 19, 2025, 11:18 IST Shares of Alembic Pharmaceuticals Ltd were in focus on Tuesday, August 19, after the company announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Macitentan Tablets, 10 mg. The product is a generic version of Actelion Pharmaceuticals' Opsumit tablets and is indicated for the treatment of pulmonary arterial hypertension (PAH) in adults to reduce the risk of disease progression and hospitalization. According to IQVIA data, the drug has an estimated market size of $1.18 billion for the 12 months ending June 2025. With this nod, Alembic's cumulative USFDA approvals now stand at 224 Abbreviated New Drug Applications (ANDAs), including 203 final approvals and 21 tentative approvals. The approval adds to the company's growing US generics portfolio, which has been a key driver of international business. Founded in 1907, Alembic is a vertically integrated pharmaceutical company with a strong presence in branded generics in India and a well-established footprint in the global generics market. The company manufactures and markets products across multiple therapeutic segments through its R&D-driven operations. Disclaimer: This article is for informational purposes only and should not be construed as investment advice. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.

Kernex Microsystems shares rise over 2% after bagging Rs 151 crore KAVACH order from West Central Railway
Kernex Microsystems shares rise over 2% after bagging Rs 151 crore KAVACH order from West Central Railway

Business Upturn

timean hour ago

  • Business Upturn

Kernex Microsystems shares rise over 2% after bagging Rs 151 crore KAVACH order from West Central Railway

By Aditya Bhagchandani Published on August 19, 2025, 10:44 IST Shares of Kernex Microsystems (India) Ltd gained over 2% in Monday's trade after the company announced a fresh order win for the Indian Railways' indigenous KAVACH Automatic Train Protection (ATP) system. At 10:43 am, the stock was trading at ₹1,076 apiece on the NSE, up 2.31% (₹24.30) from the previous close of ₹1,051.70. During the session, the stock touched a high of ₹1,079.70 and a low of ₹999.20. Kernex currently commands a market capitalisation of ₹18.10 billion and has delivered sharp gains from its 52-week low of ₹621.55, though still off its high of ₹1,580. The company, through its Kernex–KEC Consortium, secured an order worth ₹151.41 crore (including GST) from West Central Railway, Bhopal Division. The scope of work involves deployment of the KAVACH ATP system on the UHF backbone along with optical fibre cable (OFC) and route diversity. The project will be completed in 600 days across sections including Itarsi–Khandwa and Bina–Ruthiyai . With this contract, Kernex's cumulative KAVACH order book since April 2024 has risen to ₹3,136.53 crore, underscoring strong momentum in the rail safety modernisation drive. Kernex, a niche player in railway safety and signalling solutions, continues to benefit from the government's aggressive push towards rail safety. Analysts say the company's expanding execution pipeline could further support stock performance, though valuations remain on the higher side with a P/E ratio of 36.03. Disclaimer: This article is for informational purposes only and should not be construed as investment advice. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store